Abiopharma

Clinical trial NCT05551793 updates: 1. completion date: 2027-11-03 → 2028-10-31 2. primary completion date: 2027-11-03 → 2027-11-30 3. enrollment: 68 → 76 participants

Clinical trial NCT07029711 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2027-05-18 → 2027-01-06 3. primary completion date: 2027-04-20 → 2026-12-02 4. enrollment: 225 → 208 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07340190: status: NOT_YET_RECRUITING → RECRUITING.

Clinical trial NCT06300450 updates: 1. completion date: 2026-07-30 → 2026-12-30 2. primary completion date: 2026-02-28 → 2026-12-28

Clinical trial NCT05838482 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2026-06-01 → 2026-04-30 3. primary completion date: 2026-06-01 → 2026-04-30 4. enrollment: 100 → 45 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT06325566 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2027-10-01 → 2028-07-01 3. primary completion date: 2026-10-01 → 2027-07-01

Clinical trial NCT07537478 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-05-01 → 2026-05-28

Clinical trial NCT04485559: status: SUSPENDED → RECRUITING.

Clinical trial NCT03424005: enrollment: 792 → 1132 participants.

Clinical trial NCT07455747: start date: 2026-05-01 → 2026-06-01.